Oorsprong van het eerstegraads netwerk van Mary Carmen Diez
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
17
| Holding Company | Medical Specialties | 17 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Mary Carmen Diez via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
IBA SA
IBA SA Household/Personal CareConsumer Non-Durables Part of L'Oréal SA, IBA SA is a French company that manufactures and distributes air care and cleaning products. The company is based in Maisons Alfort, France. | Household/Personal Care | Director/Board Member | |
RENEURON GROUP PLC | Pharmaceuticals: Major | Director/Board Member | |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
GROUPE BRUXELLES LAMBERT SA | Financial Conglomerates | Director/Board Member | |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
GlaxoSmithKline Biologicals NV
GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Corporate Officer/Principal | |
BNP PARIBAS FORTIS SA | Major Banks | Director/Board Member | |
GlaxoSmithKline Chongqing Co. Ltd.
GlaxoSmithKline Chongqing Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Aurora Optoelectronics Co., Ltd., GlaxoSmithKline Chongqing Co. Ltd. is a pharmaceutical company based in Chongqing, CN. GlaxoSmithKline Chongqing Co. was acquired by Aurora Optoelectronics Co., Ltd. from GSK Plc on December 31, 2004 for $12.81 million. The Chinese company manufactures pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Kiel | College/University | Doctorate Degree | |
Universidad Complutense de Madrid | College/University | Graduate Degree | |
Instituto de Empresa SL | College/University | Masters Business Admin Graduate Degree | |
University of Hannover | College/University | Doctorate Degree | |
Katholieke Universiteit Leuven | College/University | Doctorate Degree Graduate Degree | |
University of Granada | College/University | Undergraduate Degree | |
Consejo Superior de Investigaciones Científicas | College/University | Doctorate Degree | |
Aventis Pharma AG | Corporate Officer/Principal | ||
Hasselt University | College/University | Doctorate Degree | |
BANCO SANTANDER, S.A. | Major Banks | Corporate Officer/Principal | |
Cellerix SA
Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Chief Executive Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer General Counsel | |
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Private Equity Investor | |
Leids Universitair Medisch Centrum
Leids Universitair Medisch Centrum Hospital/Nursing ManagementHealth Services Leids Universitair Medisch Centrum provides medical research, patient care, training, and education. The firm offers fundamental medical and applied clinical research. The company was founded in 1996 and is headquartered in Leiden, the Netherlands. | Hospital/Nursing Management | Corporate Officer/Principal | |
Araclon Biotech SL
Araclon Biotech SL Miscellaneous Commercial ServicesCommercial Services Araclon Biotech SL researches and develops therapies and diagnostic methods for Alzheimer’s disease. Its research areas include early diagnosis of Alzheimer’s disease; therapy for Alzheimer’s disease; development of a predictive test for the Alzheimer’s disease in asymptomatic individuals; and development of therapy for Parkinson’s disease. The company was founded on January 27, 2004 and is headquartered in Zaragoza, Spain. | Miscellaneous Commercial Services | Director/Board Member | |
AiCuris GmbH & Co. KG
AiCuris GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Nancy-Université | College/University | Doctorate Degree | |
Universitat Autònoma de Barcelona | College/University | Graduate Degree | |
VCN Biosciences SL
VCN Biosciences SL Miscellaneous Commercial ServicesCommercial Services Part of Theriva Biologics, Inc., VCN Biosciences SL is a clinical-stage immuno-oncology company based in Barcelona, Spain. The Spanish company focuses on developing the next generation of oncolytic adenoviruses that can obtain clinical activity after systemic administration and remodel the complex matrix in the tumor to allow enhanced spreading of therapeutic molecules and the immune system. VCN Biosciences' lead product, VCN-01, is a unique oncolytic adenovirus being studied in clinical trials for cancers for which there is no cure, including pancreatic carcinoma and retinoblastoma. The company was founded by Ramon Alemany. VCN Biosciences was acquired by Theriva Biologics, Inc. from Grifols SA on March 10, 2022 for $92.02 million. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Gri-Cel SA
Gri-Cel SA Financial ConglomeratesFinance Part of Grifols SA, Gri-Cel SA provides investment services. The company is based in Barcelona, Spain. The CEO of the Spanish company is Dirk Büscher. | Financial Conglomerates | Chief Executive Officer Chief Operating Officer | |
BePharBel Manufacturing SA
BePharBel Manufacturing SA Pharmaceuticals: MajorHealth Technology BePharBel Manufacturing SA manufactures and distributes pharmaceutical products. Its products include drugs, tuberculosis and food supplements and cosmetics. The company was founded on March 26, 2012 and is headquartered in Courcelles, Belgium. | Pharmaceuticals: Major | Chief Executive Officer | |
OncoDNA SA
OncoDNA SA Medical/Nursing ServicesHealth Services OncoDNA SA develops and provides diagnostic and analytical tools for cancer treatment. The firm offers treatment options, integrated biological review, monitoring, pathology and DNA sequencing. The company was founded by Jean-Pol Detiffe on November 29, 2012 and is headquartered in Gosselies, Belgium. | Medical/Nursing Services | Chief Executive Officer Director/Board Member | |
Janssen Vaccines AG
Janssen Vaccines AG Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Vaccines AG is a Swiss company that manufactures and distributes vaccines and immunotherapeutic products. The company is based in Bern, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Arcarios NV | Director/Board Member | ||
Aelix Therapeutics SL
Aelix Therapeutics SL BiotechnologyHealth Technology Aelix Therapeutics SL researches and develops therapies for HIV. It develops therapeutic vaccines and immunotherapies to treat HIV infection. The firm is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was founded by Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Jordi Naval is headquartered in Barcelona, Spain. | Biotechnology | Corporate Officer/Principal | |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Chairman Chief Executive Officer | |
Vaxxilon AG
Vaxxilon AG BiotechnologyHealth Technology Part of Johnson & Johnson, Vaxxilon AG is a Swiss company that develops and manufactures novel synthetic vaccines. The company is based in Reinach, Switzerland. | Biotechnology | Director/Board Member | |
Sensia SL | Director/Board Member | ||
Gsk Biologicals
Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Gsk Biologicals is a Belgian company that specializes in researching, developing, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. The private company is based in Wavre, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer | |
Aquanima Management Consulting
Aquanima Management Consulting Miscellaneous Commercial ServicesCommercial Services Aquanima Management Consulting provides management consulting services. The private company is based in Madrid, Spain. | Miscellaneous Commercial Services | Director/Board Member | |
Asociacion De Empresas Biotecnologicas
Asociacion De Empresas Biotecnologicas BiotechnologyHealth Technology Asociacion De Empresas Biotecnologicas operates as a Spanish biotechnology company. The private company is based in Madrid, Spain. | Biotechnology | Director/Board Member | |
Universite Paris Cite | College/University | Doctorate Degree | |
BIOSENIC SA | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Genetrix SL
Genetrix SL BiotechnologyHealth Technology Genetrix SL develops biotechnological solutions. It is comprised of technology and biomedicine companies in order to maximize the value of the Group. The company was founded in May 20, 2003 and is headquartered in Madrid, Spain. | Biotechnology | Chief Tech/Sci/R&D Officer | |
BESIX Group NV
BESIX Group NV Engineering & ConstructionIndustrial Services BESIX Group NV engages in the provision of construction and engineering solutions. Its business units include real estate, contracting, and concessions and assets. The real estate business realizes residential and office buildings in prime locations. The Contracting business comprises buildings, marine works, infrastructure, industry, environment; and sports and leisure. The concessions and assets business acquires, invests, operates, and maintains projects. The company was founded in 1909 and is headquartered in Woluwe-Saint-Lambert, Belgium. | Engineering & Construction | Director/Board Member |
Statistieken
Internationaal
Spanje | 17 |
België | 15 |
Duitsland | 6 |
Zwitserland | 5 |
Nederland | 4 |
Sectoraal
Health Technology | 22 |
Consumer Services | 12 |
Commercial Services | 7 |
Finance | 6 |
Health Services | 3 |
Operationeel
Director/Board Member | 51 |
Corporate Officer/Principal | 35 |
Chairman | 25 |
Chief Executive Officer | 15 |
Independent Dir/Board Member | 14 |
Sterkste connecties
Insiders | |
---|---|
Russell Greig | 31 |
Eduardo Bravo Fernández de Araoz | 19 |
Marie Paule Richard | 15 |
June Almenoff | 14 |
Claudia D'Augusta | 12 |
Dirk Reyn | 12 |
Jean Stephenne | 12 |
Maria Pascual | 8 |
Dirk Büscher | 7 |
Wilfried Dalemans | 6 |
Susana Rojo | 6 |
José Vicente Terencio | 5 |
An Moonen | 5 |
Anne Leselbaum | 5 |
Sebastian Wehle | 3 |
- Beurs
- Insiders
- Mary Carmen Diez
- Bedrijfsconnecties